氨基氧化酶抑制剂。它们在临床医学中的当前地位。
The aminase oxidase inhibitors. Their current place in clinical medicine.
作者信息
OBLATH R W, GRIFFITH G C
出版信息
Calif Med. 1960 Dec;93(6):343-6.
Abstract
Development of the MAO-inhibitors has been an important advance in the treatment of tuberculosis, mental depression, several of the collagen diseases, hypertension and angina pectoris. Treatment must be carefully controlled and individualized. A sufficient number of MAO-inhibitors is available at present to afford ready and correct selection of the proper one for a given patient and disease. Provided such care is observed, treatment is most successful and side effects are few and, as a rule, readily corrected.
摘要
单胺氧化酶抑制剂的研制是治疗肺结核、精神抑郁症、几种胶原性疾病、高血压和心绞痛方面的一项重要进展。治疗必须严格控制并因人而异。目前已有足够数量的单胺氧化酶抑制剂可供使用，以便为特定的患者和疾病迅速且正确地选择合适的药物。只要遵循这种谨慎态度，治疗最为成功，副作用很少，而且通常很容易纠正。
相似文献
1
The aminase oxidase inhibitors. Their current place in clinical medicine.氨基氧化酶抑制剂。它们在临床医学中的当前地位。
Calif Med. 1960 Dec;93(6):343-6.
2
Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.心脏病学中使用单胺氧化酶抑制剂治疗的理论背景。
Am J Cardiol. 1960 Dec;6:1121-4. doi: 10.1016/0002-9149(60)90374-x.
3
The use of monoamine oxidase inhibitors as adjuncts in the treatment of hypertension and angina pectoris.单胺氧化酶抑制剂在高血压和心绞痛治疗中作为辅助药物的应用。
Am J Cardiol. 1960 Dec;6:1136-41. doi: 10.1016/0002-9149(60)90377-5.
4
Monoamine oxidase inhibitors in the treatment of angina pectoris.单胺氧化酶抑制剂在心绞痛治疗中的应用。
Angiology. 1960 Feb;11:76-80. doi: 10.1177/000331976001100115.
5
Monoamine oxidase inhibitors and angina pectoris.单胺氧化酶抑制剂与心绞痛
Angiology. 1960 Feb;11:67-75. doi: 10.1177/000331976001100114.
6
Experiences in the treatment of angina pectoris with monoamine oxidase inhibitors.单胺氧化酶抑制剂治疗心绞痛的经验。
J Am Geriatr Soc. 1961 Jun;9:427-31. doi: 10.1111/j.1532-5415.1961.tb01620.x.
7
On the mechanism of action of monoamine oxidase inhibitors in angina pectoris.单胺氧化酶抑制剂治疗心绞痛的作用机制
J Am Geriatr Soc. 1961 Jun;9:410-8. doi: 10.1111/j.1532-5415.1961.tb01616.x.
8
Coronary artery disease: the use of monoamine oxidase inhibitors in the treatment of the anginal syndrome.冠状动脉疾病：单胺氧化酶抑制剂在心绞痛综合征治疗中的应用。
Angiology. 1960 Feb;11:84-5. doi: 10.1177/000331976001100117.
9
Tersavid (RO 4-1634), an amine oxidase inhibitor, for the treatment of angina pectoris. Up to 15 months follow-up study.
Dis Chest. 1961 Apr;39:459-63.
10
[The monoamine oxidase inhibitors in cardiovascular therapeutics (angina pectoris and arterial hypertension)].
Sem Hop Ther Paris. 1960 Oct;36:710-6.
引用本文的文献
1
The Role of Mitochondria in Metabolic Syndrome-Associated Cardiomyopathy.线粒体在代谢综合征相关心肌病中的作用。
Oxid Med Cell Longev. 2022 Jun 23;2022:9196232. doi: 10.1155/2022/9196232. eCollection 2022.
本文引用的文献
1
Effect of iproniazid on survival in the dog, following acute coronary occlusion.异烟酰异丙肼对犬急性冠状动脉闭塞后存活情况的影响。
Ann N Y Acad Sci. 1959 Sep 17;80:981-7. doi: 10.1111/j.1749-6632.1959.tb49273.x.
2
Clinical and pharmacological considerations on mode of action of monoamine oxidase inhibitors.单胺氧化酶抑制剂作用机制的临床与药理学考量
Dis Nerv Syst. 1960 Mar;21(3)Suppl:89-100.
3
In vitro and inhibition of amine oxidases.体外及对胺氧化酶的抑制作用。
Ann N Y Acad Sci. 1959 Sep 17;80:583-9. doi: 10.1111/j.1749-6632.1959.tb49236.x.
4
[Effect of isopropyl isonicotinic acid hydrazide in 100 cases of angina pectoris].异烟肼异丙酯治疗100例心绞痛的疗效观察
Schweiz Med Wochenschr. 1958 Sep 6;88(36):882-6.
5
The effect of marsilid on blood pressure in hypertensive patients.吗氯贝胺对高血压患者血压的影响。
J Clin Exp Psychopathol. 1958 Apr-Jun;19(2, Suppl. 1):152-4; discussion 154-62.
6
The effects of iproniazid phosphate (marsilid) on hypertension.磷酸异烟肼（闷可乐）对高血压的影响。
Angiology. 1957 Apr;8(2):198-200. doi: 10.1177/000331975700800210.
7
On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine).关于异烟酰异丙肼（2-异丙基-1-异烟酰肼）增强药物作用的机制
J Pharmacol Exp Ther. 1956 Apr;116(4):480-5.
Zotero 插件